Could Zepid be viable in domestic anti-impotence drug market?

Published: 2011-09-14 06:56:00
Updated: 2011-09-14 06:56:00
The Korea Food and Drug Administration (KFDA) recently approved the domestic sale of Zepid, a new type of anti-impotency drug.

Created by JW Pharmaceutical, Zepid is expected to be launched in the last quarter of this year, but concerns are mounting over its viability in the domestic erectile ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.